Balance Sheet
Cash Flow Statement
AmortizationCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Sony (SNEJF) Asset Writedowns and Impairment (2016 - 2018)

Historic Asset Writedowns and Impairment for Sony (SNEJF) over the last 10 years, with Q1 2018 value amounting to -$448.9 million.

  • Sony's Asset Writedowns and Impairment rose 398.07% to -$448.9 million in Q1 2018 from the same period last year, while for Mar 2018 it was -$448.9 million, marking a year-over-year increase of 398.07%. This contributed to the annual value of -$439.2 million for FY2018, which is 1064.12% up from last year.
  • According to the latest figures from Q1 2018, Sony's Asset Writedowns and Impairment is -$448.9 million, which was up 398.07% from -$550.3 million recorded in Q4 2017.
  • Over the past 5 years, Sony's Asset Writedowns and Impairment peaked at -$436.1 million during Q3 2017, and registered a low of -$928.4 million during Q4 2014.
  • For the 5-year period, Sony's Asset Writedowns and Impairment averaged around -$624.2 million, with its median value being -$643.4 million (2014).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 1000.92% in 2014, then skyrocketed by 3471.46% in 2016.
  • Quarter analysis of 5 years shows Sony's Asset Writedowns and Impairment stood at -$928.4 million in 2014, then rose by 4.3% to -$888.5 million in 2015, then increased by 22.09% to -$692.3 million in 2016, then grew by 20.51% to -$550.3 million in 2017, then increased by 18.42% to -$448.9 million in 2018.
  • Its Asset Writedowns and Impairment was -$448.9 million in Q1 2018, compared to -$550.3 million in Q4 2017 and -$436.1 million in Q3 2017.